Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene

被引:195
作者
Grünig, E
Janssen, B
Mereles, D
Barth, U
Borst, MM
Vogt, IR
Fischer, C
Olschewski, H
Kuecherer, HF
Kübler, W
机构
[1] Univ Heidelberg, Inst Human Genet, D-69120 Heidelberg, Germany
[2] Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany
[3] Univ Giessen, Dept Internal Med 2, Giessen, Germany
关键词
hypertension; pulmonary; echocardiography; genetics;
D O I
10.1161/01.CIR.102.10.1145
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Familial primary pulmonary hypertension (PPH) is an autosomal-dominant inherited disease with incomplete penetrance and poor prognosis. This study was performed to examine whether asymptomatic carriers of a mutated PPH gene can be identified at an early stage by their pulmonary artery systolic pressure (PASP) response to exercise. Methods and Results-Stress Doppler echocardiography during supine bicycle exercise and genetic linkage analysis were performed on 52 members of 2 families with PPH. In 4 PPH patients, the mean PASP was increased at rest (73+/16 mm Hg). Fourteen additional family members with normal PASP at rest revealed an abnormal PASP response to exercise (from 23+/-4 to 56+/-11 mm Hg) without secondary cause (abnormal response [AR] group). Twenty-seven other members (NR group) revealed a normal PASP response (maximal pressure <40 mm Hg) to exercise (from 24+/-4 to 37+/-3 mm Hg, P<0.0001), All 14 AR but only 2 NR members shared the risk haplotype with the PPH patients. The molecular genetic analysis supported linkage to chromosome 2q31-32 with a logarithm of the odds score of 4.4 when the 4 patients and the 14 AR members were classified as affected, Conclusions-We conclude that the pathological rise of PASP in asymptomatic family members is linked to chromosome 2q31-32 and is probably an early sign of PPH. Therefore, stress Doppler echocardiography may be a useful tool to identify persons at risk for PPH even before pulmonary artery pressures at rest are elevated.
引用
收藏
页码:1145 / 1150
页数:6
相关论文
共 23 条
  • [1] Appetite-suppressant drugs and the risk of primary pulmonary hypertension
    Abenhaim, L
    Moride, Y
    Brenot, F
    Rich, S
    Benichou, J
    Kurz, X
    Higenbottam, T
    Oakley, C
    Wouters, E
    Aubier, M
    Simonneau, G
    Begaud, B
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (09) : 609 - 616
  • [2] ABNORMAL PULMONARY-ARTERY PRESSURE PROFILE AFTER CARDIAC TRANSPLANTATION - AN EXERCISE DOPPLER-ECHOCARDIOGRAPHIC STUDY
    BARBANT, SD
    REDBERG, RF
    TUCKER, KJ
    CHATTERJEE, K
    DEMARCO, T
    FOSTER, E
    SCHILLER, NB
    [J]. AMERICAN HEART JOURNAL, 1995, 129 (06) : 1185 - 1192
  • [3] A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    Barst, RJ
    Rubin, LJ
    Long, WA
    McGoon, MD
    Rich, S
    Badesch, DB
    Groves, BM
    Tapson, VF
    Bourge, RC
    Brundage, BH
    Koerner, SK
    Langleben, D
    Keller, CA
    Murali, S
    Uretsky, BF
    Clayton, LM
    Jobsis, MM
    Blackburn, SD
    Shortino, D
    Crow, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) : 296 - 301
  • [4] DETERMINATION OF RIGHT ATRIAL AND RIGHT VENTRICULAR SIZE BY 2-DIMENSIONAL ECHOCARDIOGRAPHY
    BOMMER, W
    WEINERT, L
    NEUMANN, A
    NEEF, J
    MASON, DT
    DEMARIA, A
    [J]. CIRCULATION, 1979, 60 (01) : 91 - 100
  • [5] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY
    DALONZO, GE
    BARST, RJ
    AYRES, SM
    BERGOFSKY, EH
    BRUNDAGE, BH
    DETRE, KM
    FISHMAN, AP
    GOLDRING, RM
    GROVES, BM
    KERNIS, JT
    LEVY, PS
    PIETRA, GG
    REID, LM
    REEVES, JT
    RICH, S
    VREIM, CE
    WILLIAMS, GW
    WU, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) : 343 - 349
  • [6] Primary pulmonary hypertension
    Gaine, SP
    Rubin, LJ
    [J]. LANCET, 1998, 352 (9129) : 719 - 725
  • [7] Stress Doppler echocardiography for identification of susceptibility to high altitude pulmonary edema
    Grünig, E
    Mereles, D
    Hildebrandt, W
    Swenson, ER
    Kübler, W
    Kuecherer, H
    Bärtsch, P
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (04) : 980 - 987
  • [8] GURTNER HP, 1975, PROG RESPIR RES, V9, P295
  • [9] HATANO S, 1976, CARDIOVASC DIS, V146, P79
  • [10] Long term intravenous prostaglandin (epoprostenol or iloprost) for treatment of severe pulmonary hypertension
    Higenbottam, T
    Butt, AY
    McMahon, A
    Westerbeck, R
    Sharples, L
    [J]. HEART, 1998, 80 (02) : 151 - 155